This inventor holds 1 USPTO granted patent. Top assignee: Epitech Group S.p.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gabriele Marcolongo and a Patent on PEA and DHA
Introduction
Gabriele Marcolongo is an inventor associated with Milan, Italy, and Epitech Group S.p.a. His patent work concerns a proposed combination of N-palmitoylethanolamide (PEA) and docosahexaenoic acid (DHA) for use in treating autism spectrum disorder and other depressive syndromes.
Latest Patents
The available information lists 1 patent for Marcolongo: “N-palmitoylethanolamide and docosahexaenoic acid for use in the treatment of autism spectrum disorder and other depressive syndromes.” The patent describes using PEA together with DHA, particularly for conditions associated with decreased endogenous levels of allopregnanolone.
Career Highlights
Marcolongo’s listed invention focuses on a therapeutic application of two compounds. The information provided identifies Epitech Group S.p.a. as the company where he works.
Collaborations
The listed coworkers associated with Marcolongo are Francesco Della Valle and Maria Federica Della Valle.
Conclusion
Gabriele Marcolongo’s recorded patent activity centers on the proposed use of PEA and DHA in treating autism spectrum disorder and other depressive syndromes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile